Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Language
Publication year range
3.
Arch Esp Urol ; 48(10): 979-83, 1995 Dec.
Article in Spanish | MEDLINE | ID: mdl-8588730

ABSTRACT

OBJECTIVES: The present study describes two patients with retroperitoneal fibrosis following prolonged use of bromocriptine and pergolide for Parkinson's disease. Both patients also presented severe atheromatosis. METHODS: Similar cases reported in the literature are reviewed and the possible relationship between the use of the ergotamine derivate and severe atheromatosis is discussed. RESULTS: Both patients, a 67-year-old male and a 62-year-old female, improved after discontinuing bromocriptine, despite severe damage of renal function. CONCLUSIONS: Retroperitoneal fibrosis may develop in patients with bilateral ureteral obstruction, especially those who have received drugs that have been reported to cause the foregoing condition.


Subject(s)
Bromocriptine/adverse effects , Dopamine Agonists/adverse effects , Pergolide/adverse effects , Retroperitoneal Fibrosis/chemically induced , Aged , Female , Humans , Male , Middle Aged , Parkinson Disease/drug therapy
SELECTION OF CITATIONS
SEARCH DETAIL
...